Trial Profile
A Clinical Trial Gathering Insight of Patient Reported Factors That Influence Preference Following Once Daily Topical Treatment With LEO 90100 Aerosol Foam and Daivobet Gel in Subjects With Psoriasis Vulgaris
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Jul 2018
Price :
$35
*
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary) ; Betamethasone-dipropionate/calcipotriol
- Indications Plaque psoriasis
- Focus Registrational; Therapeutic Use
- Acronyms PSO-INSIGHTFUL
- Sponsors LEO Pharma
- 31 Aug 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 30 Jun 2015 Planned End Date changed from 1 May 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
- 30 Jun 2015 Planned primary completion date changed from 1 May 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov.